Neural Analytics, Inc., a Los Angeles, CA-based medical robotics company developing and commercializing technologies to measure and track brain health, raised approximately $22m in Series C funding.
The round, which brought total funding to approximately $66m, was led by Alpha Edison.
Led by Leo Petrossian, Ph.D., Co-Founder and Chief Executive Officer, Neural Analytics provides the Lucid Robotic System, an autonomous all-in-one robotic neurovascular ultrasound device that integrates ultrasound, robotics and machine learning to non-invasively search, measure and display objective brain blood flow information in real-time.
The system can be utilized throughout the patient care chain: from the use of a bubble study in the identification of right-to-left shunts, to monitoring for cerebral blood flow velocities in real time, to emboli monitoring.
The platform is currently active at select centers around the United States and the company will continue to expand its commercialization.